Valuation: Eckert & Ziegler SE

Market Cap 860M 992M 807M 735M 1.38B 94.52B 1.4B 9.5B 3.7B 47.46B 3.72B 3.64B 158B P/E 2026 *
16.5x
P/E 2027 * 15.6x
Enterprise Value 744M 858M 698M 636M 1.2B 81.77B 1.21B 8.22B 3.2B 41.06B 3.22B 3.15B 137B EV / Sales 2026 *
2.34x
EV / Sales 2027 * 2.16x
Free-Float
67.36%
Yield 2026 *
1.42%
Yield 2027 * 1.45%
1 day-0.14%
1 week+2.37%
Current month+0.07%
1 month-7.92%
3 months-9.54%
6 months-8.53%
Current year-9.19%
1 week 13.52
Extreme 13.52
14.09
1 month 13.25
Extreme 13.25
14.97
Current year 13.25
Extreme 13.25
16.58
1 year 13.25
Extreme 13.25
21.28
3 years 9.69
Extreme 9.686666
23
5 years 9.69
Extreme 9.686666
47.07
10 years 1.72
Extreme 1.716916
47.07
Manager TitleAgeSince
Chief Executive Officer 59 2023-06-06
Chief Tech/Sci/R&D Officer - 2024-12-31
Chief Operating Officer 59 2024-12-31
Director TitleAgeSince
Chairman 57 2023-06-06
Director/Board Member 66 2013-12-31
Director/Board Member 58 2016-12-31
Change 5-day change 1-year change 3-year change Capi.($)
-0.14%+2.37% - - 1.01B
-0.97%+3.69%+28.58%-34.52% 17.18B
-0.80%-5.12%-8.96%+92.06% 1.76B
-1.36%+0.66%-27.95%+22.77% 1.01B
+6.00%-15.64%-37.27%-80.97% 959M
-0.70%+49.15%+88.84%-11.47% 783M
+2.02%+3.39%-37.37%-50.47% 677M
+6.68%+16.06%-41.91%-42.31% 595M
0.00%+5.46%-44.70%-43.57% 415M
+0.10%+18.58%+55.83%+38.97% 411M
Average +1.08%+9.51%-2.77%-12.17% 2.64B
Weighted average by Cap. -0.36%+5.50%+18.29%-23.40%

Financials

2026 *2027 *
Net sales 319M 367M 299M 272M 512M 35.01B 520M 3.52B 1.37B 17.58B 1.38B 1.35B 58.54B 340M 392M 319M 291M 547M 37.4B 556M 3.76B 1.46B 18.78B 1.47B 1.44B 62.55B
Net income 51.68M 59.57M 48.45M 44.14M 83.03M 5.68B 84.34M 570M 222M 2.85B 224M 219M 9.49B 53.08M 61.19M 49.77M 45.34M 85.28M 5.83B 86.63M 586M 228M 2.93B 230M 225M 9.75B
Net Debt -116M -134M -109M -99.15M -187M -12.75B -189M -1.28B -499M -6.4B -502M -491M -21.33B -126M -145M -118M -107M -202M -13.79B -205M -1.39B -540M -6.92B -543M -531M -23.06B
Logo Eckert & Ziegler SE
Eckert & Ziegler SE is a Germany-based Company, which is a provider of isotope technology for medical, scientific and industrial use with focus on cancer therapy, industrial radiometry and nuclear-medical imaging. The Company operates through three segments: Radiation Therapy, Isotope Products and Radiopharma. The Radiation Therapy segment operates through Eckert & Ziegler BEBIG and produces and distributes medical products for the treatment of cancer using brachytherapy. The Isotope Products segment provides sealed and unsealed radiation sources for medical imaging, industrial gauging, measurement and analysis, reference, calibration and environmental monitoring sources and solutions, as well as bulk radioisotopes for pharmaceutical, therapeutic and industrial product manufacturers. The Radiopharma segment specializes in molecular imaging and nuclear medicine, and supplies various radiopharmaceuticals, radiochemicals and related equipment.
Employees
1,100
Date Price Change Volume
26-08-12 €13.84 -0.14% 0
26-08-11 €13.86 -0.29% 0
26-08-10 €13.90 -1.35% 1,200
26-08-07 €14.09 +4.22% 350
26-08-06 €13.52 -0.88% 0
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
13.75EUR
Average target price
21.60EUR
Spread / Average Target
+57.09%

Quarterly revenue - Rate of surprise